Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ASTRAZENECA Latest News

FEB 25, 2014 - Wall Street Journal

A Must Read - Share

FDA Approves Myalept for Leptin Deficiency Treatment

Research-based biopharmaceutical company AstraZeneca PLC said Tuesday the U.S. Food and Drug Administration approved orphan drug MYALEPT.

Tags: FDA Approves Myalept for Leptin Deficiency Treatment,  Astrazeneca Latest News